2019
Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial
Wei D, Liu J, Sun Y, Shi Y, Zhang B, Liu J, Tan J, Liang X, Cao Y, Wang Z, Qin Y, Zhao H, Zhou Y, Ren H, Hao G, Ling X, Zhao J, Zhang Y, Qi X, Zhang L, Deng X, Chen X, Zhu Y, Wang X, Tian L, Lv Q, Ma X, Zhang H, Legro R, Chen Z. Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial. The Lancet 2019, 393: 1310-1318. PMID: 30827784, DOI: 10.1016/s0140-6736(18)32843-5.Peer-Reviewed Original ResearchConceptsFrozen single blastocyst transferFresh single blastocyst transferSingle blastocyst transferElective single embryo transferRisk of pre-eclampsiaFrozen blastocyst transferBlastocyst transferLivebirth rateSevere ovarian hyperstimulation syndromePre-eclampsiaOvulatory womenPregnancy rateEmbryo transferOvarian hyperstimulation syndromeAcademic fertility centreFrozen-thawed single blastocyst transferHigher risk of pre-eclampsiaIn vitro fertilisationIncreased risk of pre-eclampsiaFrozen embryo transferExtended embryo cultureSingle embryo transferFertility centreHyperstimulation syndromeLower pregnancy rate
2009
The use of lead follicle diameter to initiate gonadotropin-releasing hormone antagonist does not affect in vitro fertilization clinical pregnancy, implantation, or live birth rates: a prospective, randomized study
Dayal M, Frankfurter D, O'Hern C, Peak D, Dubey A, Gindoff P. The use of lead follicle diameter to initiate gonadotropin-releasing hormone antagonist does not affect in vitro fertilization clinical pregnancy, implantation, or live birth rates: a prospective, randomized study. Fertility And Sterility 2009, 92: 2047-2049. PMID: 19591990, DOI: 10.1016/j.fertnstert.2009.05.083.Peer-Reviewed Original ResearchConceptsLive birth rateIncidence of severe ovarian hyperstimulation syndromeClinical pregnancyBirth rateSevere ovarian hyperstimulation syndromeOvarian hyperstimulation syndromeGnRH antagonist administrationHyperstimulation syndromeIVF cyclesGonadotropin-releasing hormone antagonistRandomized studyLead follicleAntagonist administrationHormone antagonistLH surgeDominant follicleFollicle diameterIVFPregnancyGnRHFolliclesImplantation
2005
Ascites
Kbalid S, Garcia-Tsao G. Ascites. Clinical Gastroenterology 2005, 285-299. DOI: 10.1007/978-1-59259-885-4_19.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsSevere ovarian hyperstimulation syndromeOvarian hyperstimulation syndromeCause of ascitesAccumulation of fluidHyperstimulation syndromePeritoneal malignancyCompensated cirrhosisPeritoneal tuberculosisPortal hypertensionCommon complicationCardiac failureProspective studyCommon causeDifferential diagnosisPeritoneal cavityAscitesCirrhosisCumulative probabilityPatientsCauseHypertensionComplicationsMalignancySyndromeEtiology
1994
Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors*
Lyons CA, Wheeler CA, Frishman GN, Hackett RJ, Seifer DB, Haning RV. Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors*. Human Reproduction 1994, 9: 792-799. PMID: 7929724, DOI: 10.1093/oxfordjournals.humrep.a138598.Peer-Reviewed Original ResearchConceptsLate ovarian hyperstimulation syndromeOvarian hyperstimulation syndromeSevere ovarian hyperstimulation syndromeNumber of oocytesHyperstimulation syndromeEarly ovarian hyperstimulation syndromePost-human chorionic gonadotrophinDifferent risk factorsStepwise logistic regressionSeries of casesDay-hCGMultiple gestationsClinical predictorsFertilization cyclesGestational sacEarly pregnancyLate presentationOestradiol concentrationsSerum concentrationsEgg retrievalRisk factorsHigh oestradiolAcute effectsChorionic gonadotrophinRetrospective analysis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply